Supernus (SUPN) Share-based Compensation (2022 - 2026)
Supernus Pharmaceuticals' Share-based Compensation was $8.93 million in Q3 2026, up 14.2% from $7.83 million a year earlier and up 3.4% from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) Share-based Compensation (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' Share-based Compensation was $35.7 million through Sep 30, 2026, up 15.1% year-over-year; for FY2025, it was $33.05 million, up 19.1% from FY2024.
- Share-based Compensation has now increased for three consecutive years, with a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $27.76 million in FY2024 (+3.7%), $26.76 million in FY2023 (+52.3%), $17.57 million in FY2022 (-1.9%) and $17.91 million in FY2021 (+8.1%).
- Quarterly Share-based Compensation has moved between $4.03 million (Q1 2022) and $9.65 million (Q4 2025) over five years.
- Compared with a year earlier, Share-based Compensation has increased for eight straight quarters, with growth averaging 16.6% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2023 (growth of 58.9%); the worst was Q2 2022 (a decline of 21.5%).
- Per Business Quant data, SUPN's Share-based Compensation in the three quarters before Q3 2026 was $8.64 million (Q2 2026), $8.48 million (Q1 2026) and $9.65 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 8.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.00 Mn |
| Jun 30, 2026 | 11.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 6.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
API Access
Supernus Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();